Navigation

Donate:

Please help support the work of the CIHR Canadian HIV Trials Network (CTN) by contacting the St. Paul’s Hospital Foundation by email nmacleod@providencehealth.bc.ca or calling 604.806.8912.

Let them know that you would like to direct your donation in support of capacity building activities at the CTN. Your contribution will be used to support activities not funded by our main sponsor that continue to build capacity domestically and internationally and that support CTN’s overall mission of research for treatments, preventions and a cure for HIV/AIDS.

Donations of $25 or more are eligible to receive an official tax receipt.

Our initiatives include:

  • Training new investigators through seminars and international conferences
  • Scaling up clinical trial skills for investigators, clinical research nurses, data managers, and administrators
  • Involving community representation through consultations with those affected and living with HIV and AIDS

For more information on any of our programs or how your support will be used, please contact the CTN at ctninfo@hivnet.ubc.ca or toll-free at 1-800-661-4664.

Thank you for your contribution!

Latest News

Canadian Guidelines on PrEP and nPEP Published

| Uncategorized | No Comments

After nearly two years of work and consultation, the first Canadian Guidelines on pre-exposure prophylaxis (PrEP) and non-occupational post-exposure prophylaxis…

Why do we need PrEP Guidelines? Ask an expert. VIDEO

| Uncategorized | No Comments

Despite efforts to reduce new incidences of HIV like condom campaigns, needle exchanges, and treatment as prevention, the actual number…

Call for Nominations: Community Advisory Committee (CAC) 2018

| Uncategorized | No Comments

The CIHR Canadian HIV Trials Network (CTN/Network) is an innovative partnership funded by the Canadian Institutes of Health Research to…

Guest Blog: Dr. Nadine Kronfli on HCV treatment in Canadian prisons

| Hepatitis C | No Comments

Persons in custody in Canadian prisons have a 25-fold higher rate of hepatitis C (HCV) infection than the general population….